Canadian Institutes of Health Research
Français Contact UsHelpSearchCanada Site
CIHR HomeAbout CIHRWhat's NewFunding OpportunitiesFunding Decisions
CIHR | IRSC
About CIHR
CIHR Institutes
Funding Health Research
Knowledge Translation and Commercialization
Partnerships
Major Strategic Initiatives
International Cooperation
Ethics
About Ethics at CIHR
CIHR Policies and Guidelines in Ethics
Policy Initiatives
Aboriginal Ethics
Institutional Conflicts of Interest
Longitudinal Cohort Studies
National Placebo Initiative
Privacy and Confidentiality
Stem Cell Research
Ethics Funding
Ethics Resources and Publications
Contact Ethics Office
News and Media
Publications
 
CIHR > Ethics > Policy Initiatives > National Placebo Initiative
y-r-bar-1.jpg (3541 bytes)National Placebo Initiativey-r-bar-r.jpg (3541 bytes)

National Placebo Initiative (NPI)

Co-sponsored by Health Canada and Canadian Institutes of Health Research

Final Report of the National Placebo Working Committee on the Appropriate Use of Placebos in Clinical Trials in Canada (July 2004)

Limited numbers of copies of the Final Report are available for distribution. Please send your requests to Ethics@cihr.gc.ca.

Both Health Canada and CIHR are currently considering recommendations of the National Placebo Working Committee for the common placebo policy and preparing to respond to the Final Report.

For further inquiries please contact

At CIHR:
Ethics Office
tel: (613) 946-4773
fax: (613) 946-0885
ethics@cihr-irsc.gc.ca 

At Health Canada:
Heather Van Dusen
Policy Bureau
Therapeutic Products Directorate
Tel: (613) 941-5515
Fax: (613) 941-6458
heather_van_dusen@hc-sc.gc.ca

Background information about National Placebo Initiative and its activities as of Spring 2004.
Modified: 2005-03-18
Reviewed: 2005-03-18
Print